leisure time -WSS

leisure time

author：entertainment 2025-10-01 02:28:23 - browse：49

Grail spent more than $1 million last quarter lobbying Congress, underscoring the urgency of the company’s bid to secure Medicare coverage for its pricey blood-based cancer screening test that has been on the market for over a year but is not widely used.

A recently posted lobbying report indicates that, during the fourth quarter of last year, the biotech spent $1.07 million on “issues related to oncology and multi-cancer early detection,” including House and Senate bills that would allow Medicare to cover multi-cancer screening tests. That figure has been rising; during the fourth quarter of 2021, the company spent $470,000 on lobbying. That’s far more than cancer and genetic testing biotechs such as Guardant Health, Myriad Genetics, and Tempus, which spent anywhere from $90,000 to nearly $300,000 on lobbying last quarter.

The growing investment in lobbying elected officials comes at a time when Grail is looking to make its test, Galleri, available to a broader swath of the population. The test, launched in 2021, can detect early signs of more than 50 cancers among people who don’t have symptoms. That’s because cancer cells release bits of DNA into the bloodstream, and Galleri spots telltale modifications to this DNA.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Fatty liver disease was alleviated by Lilly’s ‘triple

WSS

Addressing health care workers' trauma can help fight burnout

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Lupron, used to halt puberty in children, may cause lasting health problems

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

UnitedHealth argues against case alleging wrongful AI care denials

focus

leisure time

hotspot

Psychedelics group wrestles with new pharma identity

Addressing health care workers' trauma can help fight burnout

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Citing H5N1 threat, CDC urges peak flu monitoring this summer

FDA approval of Sarepta Duchenne genetic therapy gives me hope

UnitedHealth argues against case alleging wrongful AI care denials

How one medical school became remarkably diverse

Fatty liver disease was alleviated by Lilly’s ‘triple

As demand for Covid shots wanes, Moderna seeks its next success

What affirmative action's end means to a medical student

explore

H5N1 bird flu outbreak: Second human case reported, in Michigan

Investigation reveals sickle cell patients pressured into sterilizations

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Vertex cell therapy lets patients with type 1 diabetes stop insulin

UpToDate has a racism problem: Dr. Stanley Goldfarb

Undocumented workers face uncertainty as immigration law takes effect in Florida

knowledge

knowledge

entertainment

hotspot